Vimarsana
Biggest News Aggregation in the World

Page 17 - T Cells News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from T Cells. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In T Cells Today - Breaking & Trending Today

Why lung cancer doesn't respond well to immunotherapy | MIT News | Massachusetts Institute of Technology - Vimarsana News

Why lung cancer doesn't respond well to immunotherapy | MIT News | Massachusetts Institute of Technology

MIT researchers discovered why the immune system mounts such a lackluster response to lung cancer, even after treatment with immunotherapy drugs: Bacteria naturally found in the lungs help create an environment that suppresses T-cell activation in the lymph nodes near the lungs.

Source: mit.edu
Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works - Vimarsana News

Moderna's experimental cancer vaccine treats but doesn't prevent melanoma – a biochemist explains how it works

Preventive and therapeutic vaccines both train the immune system to fight disease, but they are used in different ways.

Mechanism revealed for COVID-19-related loss of smell - Vimarsana News

Mechanism revealed for COVID-19-related loss of smell

Olfactory tissue biopsies help researchers discover the mechanism responsible for COVID-19-related loss of smell, along with other long COVID symptoms.

Exhausted Cancer-Fighting T Cells Can be Reinvigorated to Protect the Immune System, New Study Finds - Vimarsana News

Exhausted Cancer-Fighting T Cells Can be Reinvigorated to Protect the Immune System, New Study Finds

Exhausted T cells could work against the immune system, but scientists found that they can decrease the suppressive nature of these tired cells.

Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target - Vimarsana News

Anti-cancer CAR-T therapy reengineers T cells to kill tumors – and researchers are expanding the limited types of cancer it can target

Immunotherapy has the potential to eliminate tumors, but works best for select patients. Engineering T cells to bypass cancer’s defenses could help expand treatment eligibility to more patients.